Resultados da pesquisa - Modesto, Irene
- A mostrar 1 - 18 resultados de 18
-
1
-
2
Comment on: “Retrospective Claims Analysis Indirectly Comparing Medication Adherence and Persistence Between Intravenous Biologics and Oral Small-Molecule Therapies in Inflammatory... Por Woolcott, John, Cappelleri, Joseph C., Sharma, Puza, Modesto, Irene
Publicado em 2020Text -
3
Worldwide post‐marketing safety surveillance experience with tofacitinib in ulcerative colitis Por Rubin, David T., Modesto, Irene, Vermeire, Séverine, Danese, Silvio, Ng, Siew C., Kwok, Kenneth K., Koram, Nana, Jones, Thomas V.
Publicado em 2021Text -
4
The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature Por Sinagra, Emanuele, Aragona, Emma, Romano, Claudia, Maisano, Simonetta, Orlando, Ambrogio, Virdone, Roberto, Tesè, Lorenzo, Modesto, Irene, Criscuoli, Valeria, Cottone, Mario
Publicado em 2012Text -
5
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry Por Agrawal, Manasi, Brenner, Erica J, Zhang, Xian, Modesto, Irene, Woolcott, John, Ungaro, Ryan C, Colombel, Jean-Frederic, Kappelman, Michael D
Publicado em 2020Text -
6
Exposure‐Response Characterization of Tofacitinib Efficacy in Moderate to Severe Ulcerative Colitis: Results From Phase II and Phase III Induction and Maintenance Studies Por Mukherjee, Arnab, Tsuchiwata, Shinichi, Nicholas, Timothy, Cook, Jack A., Modesto, Irene, Su, Chinyu, D’Haens, Geert R., Sandborn, William J.
Publicado em 2022Text -
7
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies Por Lees, Charlie W., Deuring, J. Jasper, Chiorean, Michael, Daperno, Marco, Bonfanti, Gianluca, Germino, Rebecca, Brown, Pritha Bhadra, Modesto, Irene, Edwards, Roger A.
Publicado em 2021Text -
8
Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcera... Por Brookes, Matthew J, Waller, John, Cappelleri, Joseph C, Modesto, Irene, DiBonaventura, Marco D, Bohm, Natalie, Mokgokong, Ruth, Massey, Olivia, Wood, Robert, Bargo, Danielle
Publicado em 2020Text -
9
Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomised RIVETING Trial Por Vermeire, Séverine, Su, Chinyu, Lawendy, Nervin, Kobayashi, Taku, Sandborn, William J, Rubin, David T, Modesto, Irene, Gardiner, Sean, Kulisek, Nicole, Zhang, Haiying, Wang, Wenjin, Panés, Julian
Publicado em 2020Text -
10
Efficacy and Safety of Tofacitinib Re-treatment for Ulcerative Colitis After Treatment Interruption: Results from the OCTAVE Clinical Trials Por Panés, Julian, Vermeire, Séverine, Dubinsky, Marla C, Loftus, Edward V, Lawendy, Nervin, Wang, Wenjin, Salese, Leonardo, Su, Chinyu, Modesto, Irene, Guo, Xiang, Colombel, Jean-Frederic
Publicado em 2021Text -
11
Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use Por Bargo, Danielle, Tritton, Theo, Cappelleri, Joseph C., DiBonaventura, Marco, Smith, Timothy W., Tsuchiya, Takanori, Gardiner, Sean, Modesto, Irene, Holbrook, Tim, Bluff, Daniel, Kobayashi, Taku
Publicado em 2021Text -
12
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme Por Sandborn, William J., Panés, Julian, Sands, Bruce E., Reinisch, Walter, Su, Chinyu, Lawendy, Nervin, Koram, Nana, Fan, Haiyun, Jones, Thomas V., Modesto, Irene, Quirk, Daniel, Danese, Silvio
Publicado em 2019Text -
13
Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments Por Gottlieb, Klaus, Daperno, Marco, Usiskin, Keith, Sands, Bruce E, Ahmad, Harris, Howden, Colin W, Karnes, William, Oh, Young S, Modesto, Irene, Marano, Colleen, Stidham, Ryan William, Reinisch, Walter
Publicado em 2021Text -
14
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis Por Rubin, David T., Reinisch, Walter, Greuter, Thomas, Kotze, Paulo G., Pinheiro, Marcia, Mundayat, Rajiv, Maller, Eric, Fellmann, Marc, Lawendy, Nervin, Modesto, Irene, Vavricka, Stephan R., Lichtenstein, Gary R.
Publicado em 2021Text -
15
Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data From the IBM MarketScan® Administrative Claims Database Wi... Por Curtis, Jeffrey R, Regueiro, Miguel, Yun, Huifeng, Su, Chinyu, DiBonaventura, Marco, Lawendy, Nervin, Nduaka, Chudy I, Koram, Nana, Cappelleri, Joseph C, Chan, Gary, Modesto, Irene, Lichtenstein, Gary R
Publicado em 2020Text -
16
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment... Por Sandborn, William J., Lawendy, Nervin, Danese, Silvio, Su, Chinyu, Loftus, Edward V., Hart, Ailsa, Dotan, Iris, Damião, Adérson O. M. C., Judd, Donna T., Guo, Xiang, Modesto, Irene, Wang, Wenjin, Panés, Julian
Publicado em 2021Text -
17
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States Por Agrawal, Manasi, Brenner, Erica J., Yan Mak, Joyce Wing, Zhang, Xian, Kaplan, Gilaad G., Ng, Siew C., Reinisch, Walter, Steinwurz, Flavio, Lewis, James D., Kissous-Hunt, Michele, Modesto, Irene, Ungaro, Ryan C., Colombel, Jean-Frederic, Kappelman, Michael D.
Publicado em 2021Text -
18
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy Por Canzoni, Marco, Marignani, Massimo, Sorgi, Maria Laura, Begini, Paola, Biondo, Michela Ileen, Caporuscio, Sara, Colonna, Vincenzo, Casa, Francesca Della, Conigliaro, Paola, Marrese, Cinzia, Celletti, Eleonora, Modesto, Irene, Peragallo, Mario Stefano, Laganà, Bruno, Picchianti-Diamanti, Andrea, Rosa, Roberta Di, Ferlito, Claudia, Salemi, Simonetta, D’Amelio, Raffaele, Stroffolini, Tommaso
Publicado em 2020Text